Organization
Bakersfield Dermatology, Bakersfield
1 abstract
Abstract
APREMILAST IS ASSOCIATED WITH LONG-TERM (4-YEAR) DAS-28 (CRP) REMISSION AND IMPROVEMENTS IN SKIN DISEASE: RESULTS FROM A PHASE III STUDY IN DMARD/BIOLOGIC-EXPERIENCED PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS Org: University Hospital Southampton, Southampton, United Kingdom, INIBIC-Hospital Universitario A Coruña, Galicia, Spain, Bakersfield Dermatology, Bakersfield, Celgene Corporation, Summit, University of Massachusetts Medical School, Worcester, United States,